CYP2W1 has been shown to be mainly expressed in tumors and not in normal human tissue. Has been implicated in colorectal cancer.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| SKU: | 152598 |
|---|---|
| Product description: | Cytochrome P450, family 2, subfamily W, Polypeptide 1 (CYP2W1) is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP2W1 has been shown to be mainly expressed in tumors and not in normal human tissue. Has been implicated in colorectal cancer. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2b |
| Molecular weight: | 55 kDa |
| Immunogen: | Ovalbumin-conjugated synthetic peptide – RYRLLPPPGV (C-terminal sequence) |
| Cat. #: | 152598 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer; Cell signaling and signal transduction; Metabolism; Tissue-specific biology |
| Application: | ELISA ; IHC ; WB |
| Target: | Cytochrome P450, family 2, subfamily W, Polypeptide 1 (CYP2W1) |
| Reactivity: | Human |
| Clone: | V32-P5E5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Cytochrome P450, family 2, subfamily W, Polypeptide 1 (CYP2W1) is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP2W1 has been shown to be mainly expressed in tumors and not in normal human tissue. Has been implicated in colorectal cancer. |
|---|
| Format: | Liquid |
|---|---|
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -20° C |
| Shipping conditions: | Dry ice |
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.